- Description
- Specifications
Catalog #: IHA-024
Description:
Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza A virus, strain A/Brisbane/10/07. The Influenza Virus was purified by Ultracentrifugation with 10-40 % sucrose gradient.
Purity:
Greater than 90.0% as determined byAnalysis by SDS-PAGE.
Formulation:
The H3N2 A/Brisbane/10/07 solution contains STE, 0.1 % sodium azide (NaN3) and 0.005 % thimerosal.
Stability:
A/Brisbane/10/07although stable 4 °C for 4 weeks, should be stored below -18 °C.
Please prevent freeze-thaw cycles.
Activity:
Tested with anti-influenza A monoclonal antibodies in ELISA.
Serological studies of influenza A virus, immunogen for antibody production.
Physical Appearance:
Sterile Filtered whitish (milky) solution.
Inactivation:
Thimerosal and beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices and techniques are required at work.
Usage:
Denovo Biotechnology's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
References:
Title: Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection
publication: The Rockefeller University Press, doi: 10.1084/jem.20101352
© 2011 Wrammert et al.
Link:http://jem.rupress.org/content/early/2011/01/06/jem.20101352.full
